頁籤選單縮合
題名 | 夜間遺尿=Nocturnal Enuresis |
---|---|
作者姓名(中文) | 黃詩惠; 蔡憶萱; 蘇玉惠; 郭震羣; 楊璦瑜; | 書刊名 | 藥學雜誌 |
卷期 | 34:1=134 2018.03[民107.03] |
頁次 | 頁2-7 |
分類號 | 417.57 |
關鍵詞 | 夜間遺尿; 尿床; Nocturnal enuresis; Bedwetting; |
語文 | 中文(Chinese) |
中文摘要 | 夜間遺尿 (nocturnal enuresis) 俗稱尿床 (bedwetting),定義為實際年齡五歲以上的 兒童晚上睡覺時不自主的排尿情形。依據是否有其他泌尿道症狀,分類為單症狀與多 症狀。尿床在兒童是常見的症狀,然而對於其心理社會發展是負向的,會影響孩子的 自信心與社交能力。開始治療前應先了解家屬與兒童對治療的期望。治療目標為:在 特定場合保持乾燥 (外宿)、減少尿床發生的頻率、改善尿床對孩童及家庭的影響、避 免症狀復發。治療前須對家屬與兒童進行衛教,增進治療動機。 治療主要分為非藥物與藥物治療兩大類:一、非藥物治療包括激勵療法與防潮鬧 鐘。防潮鬧鐘是第一線的選擇,治癒率高、效果持久、沒有藥物的副作用,然而須要 病人積極的參與治療。二、藥物治療主要包括 desmopressin、抗膽鹼藥物、三環抗憂鬱 劑。Desmopressin 初始治療時最快有療效,適用於外宿的使用;難治型的個案可考慮使 用抗膽鹼藥物、三環抗憂鬱劑。希望藉由治療改善病人尿床的症狀、提升生活品質。 |
英文摘要 | Nocturnal enuresis, commonly known as “Bed Wetting”, is a disorder in which episodes of urinary incontinence occurs during sleep in children ≥ 5 years of age. Depending on the presence of other symptoms, enuresis is further classified into monosymptomatic or non-monosymptomatic. Nocturnal enuresis is more commonly observed in children. It may negatively affect the child’s psychosocial development as well as interfere with the development of self-confidence and the ability to socialize. Before beginning therapy, the pediatric health care provider should define the expectations of the parents and child. The goals of interventions for nocturnal enuresis include: to stay dry on particular occasions (eg, sleepover), to reduce the number of wet nights, to reduce the impact of enuresis on the child and family, to avoid recurrence. First line intervention for both our patients and their families is education. Treatment of nocturnal enuresis can be divided into two broad categories: nonpharmacological and pharmacological. Non-pharmacological treatment mainly includes motivational therapy and alarm therapy. Alarm therapy, it is first-line management option, higher cure rate, persistent effect, no pharmacological side-effects, but requires high motivation. Pharmacological treatment includes desmopressin, anticholinergics, tricyclic antidepressants. Desmopressin has an initially high response rate and is best for episodic use (such as overnight camping). Anticholinergics and imipramine may be considered for resistant cases. Hope by treatment can improved symptom and promote quality of life. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。